The relative lethality of many commonly prescribed psychiatric medications varies tremendously.
Use brief cognitive-behavioral therapy techniques during ‘med check’ visits to enhance adherence and symptom recovery.
PARIS – Relapse-free predictors are older age, more psychotic symptoms, and early ECT response.
These disorders share features of depression, delirium, and catatonia, but key differences have major treatment implications.
David R. Spiegel, MD, discusses etiologies of disorders of diminished motivation, and how to differentiate them from depressive disorders.
Use these strategies to maximize efficacy and minimize adverse effects when prescribing a monoamine oxidase inhibitor. Second of 2 parts.
Cases That Test Your Skills
Mr. R, age 95, presents with depressive symptoms that began 6 weeks ago. He recently has lost 20 lb and is rapidly deteriorating. Which treatment...
A better understanding of the risks can lead to increased use of these highly effective agents. First of 2 parts.
Jonathan M. Meyer, MD, discusses what to tell patients about diet and monoamine oxidase inhibitors.